Patents by Inventor George Jarvis
George Jarvis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20160178594Abstract: An analyzer system for sensing a chemical characteristic of a fluid sample according to one embodiment includes a sample inlet configured to receive the sample via the sample inlet, a reagent inlet configured to receive a reagent via the reagent inlet, a reaction zone in fluid communication with the sample inlet and the reagent inlet and being configured to receive the sample from the sample inlet and the reagent from the reagent inlet for mixing the sample with the reagent; and a sensor zone in fluid communication with the reaction zone, wherein the sensor zone comprises a sensor configured to sense the chemical characteristic of the mixed sample and reagent, and further wherein the sensor zone is configured to allow automatic drainage of the mixed sample and reagent away from the sensor after the sensor has sensed the chemical characteristic of the mixed sample and reagent.Type: ApplicationFiled: December 23, 2015Publication date: June 23, 2016Inventors: George Jarvis, Victor Chung, Dave Balise, Edward Somes
-
Patent number: 8371296Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.Type: GrantFiled: May 8, 2006Date of Patent: February 12, 2013Assignee: Geno, LLCInventors: David H. Fine, Stephen J. MacDonald, David Rounbehler, David Wheeler, Jonathan L. Rolfe, George Jarvis
-
Publication number: 20120204659Abstract: In one aspect, an apparatus includes a head configured to receive a pad for sampling explosive residue on a surface and a feedback system coupled to the head. The feedback system is configured to indicate when a pressure applied by the head is greater than a minimum threshold value. In another aspect, an apparatus includes a head configured to receive a pad and rotate to apply a shear force to the pad for sampling explosive residue on a surface. The apparatus includes a feedback system coupled to the head, which is configured to restrict the shear force applied by the head to be within a predetermined range. In another aspect, a method includes applying pressure to a pad to sample explosive residue on a surface, sensing the pressure applied to the pad, and providing an indication of when the pressure applied to the pad is greater than a threshold value.Type: ApplicationFiled: September 2, 2011Publication date: August 16, 2012Applicant: L-3 COMMUNICATIONS CYTERRA CORPORATIONInventors: David H. Fine, Ravi K. Konduri, Freeman W. Fraim, George Jarvis
-
Patent number: 8221800Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.Type: GrantFiled: April 7, 2006Date of Patent: July 17, 2012Assignee: Geno LLCInventors: David H. Fine, Stephen J. MacDonald, David R. Rounbehler, David Wheeler, Jonathan L. Rolfe, George Jarvis
-
Patent number: 8066904Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.Type: GrantFiled: August 28, 2002Date of Patent: November 29, 2011Assignee: Geno LLCInventors: David H. Fine, Stephen J. MacDonald, David Rounbehler, David Wheeler, Jonathan L. Rolfe, George Jarvis
-
Patent number: 8011258Abstract: In one aspect, an apparatus includes a head configured to receive a pad for sampling explosive residue on a surface and a feedback system coupled to the head. The feedback system is configured to indicate when a pressure applied by the head is greater than a minimum threshold value. In another aspect, an apparatus includes a head configured to receive a pad and rotate to apply a shear force to the pad for sampling explosive residue on a surface. The apparatus includes a feedback system coupled to the head, which is configured to restrict the shear force applied by the head to be within a predetermined range. In another aspect, a method includes applying pressure to a pad to sample explosive residue on a surface, sensing the pressure applied to the pad, and providing an indication of when the pressure applied to the pad is greater than a threshold value.Type: GrantFiled: August 30, 2004Date of Patent: September 6, 2011Assignee: L-3 Communications CyTerra CorporationInventors: David H. Fine, Ravi K. Konduri, Freeman W. Fraim, George Jarvis
-
Publication number: 20070089739Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.Type: ApplicationFiled: May 8, 2006Publication date: April 26, 2007Applicant: GENO LLCInventors: David Fine, Stephen MacDonald, David Rounbehler, David Wheeler, Jonathan Rolfe, George Jarvis
-
Publication number: 20060172018Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.Type: ApplicationFiled: April 7, 2006Publication date: August 3, 2006Applicant: GENO LLCInventors: David Fine, Stephen MacDonald, David Rounbehler, David Wheeler, Jonathan Rolfe, George Jarvis
-
Patent number: 7040313Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.Type: GrantFiled: August 28, 2002Date of Patent: May 9, 2006Assignee: CyTerra CorporationInventors: David H. Fine, Stephen J. MacDonald, David Rounbehler, David Wheeler, Jonathan L. Rolfe, George Jarvis
-
Patent number: 7025869Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.Type: GrantFiled: August 28, 2002Date of Patent: April 11, 2006Assignee: CyTerra CorporationInventors: David H. Fine, Stephen J. MacDonald, David Rounbehler, David Wheeler, Jonathan L. Rolfe, George Jarvis
-
Publication number: 20050081655Abstract: In one aspect, an apparatus includes a head configured to receive a pad for sampling explosive residue on a surface and a feedback system coupled to the head. The feedback system is configured to indicate when a pressure applied by the head is greater than a minimum threshold value. In another aspect, an apparatus includes a head configured to receive a pad and rotate to apply a shear force to the pad for sampling explosive residue on a surface. The apparatus includes a feedback system coupled to the head, which is configured to restrict the shear force applied by the head to be within a predetermined range. In another aspect, a method includes applying pressure to a pad to sample explosive residue on a surface, sensing the pressure applied to the pad, and providing an indication of when the pressure applied to the pad is greater than a threshold value.Type: ApplicationFiled: August 30, 2004Publication date: April 21, 2005Inventors: David Fine, Ravi Konduri, Freeman Fraim, George Jarvis
-
Patent number: 6758214Abstract: A nitric oxide delivery system for delivering nitric oxide to a patient to treat a medical condition includes a container, a nitric oxide generation chamber, and a pump. The container is designed to contain a nitrogen-containing compound. The nitric oxide generation chamber includes a heat source and is designed to generate nitric oxide from the nitrogen-containing compound. The pump is designed to transfer at least a part of the nitrogen-containing compound from the container to the nitric oxide generation chamber.Type: GrantFiled: January 26, 2001Date of Patent: July 6, 2004Assignee: CyTerra CorporationInventors: David H. Fine, Freeman W. Fraim, George Jarvis
-
Publication number: 20030064115Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.Type: ApplicationFiled: August 28, 2002Publication date: April 3, 2003Inventors: David H. Fine, Stephen J. MacDonald, David Rounbehler, David Wheeler, Jonathan L. Rolfe, George Jarvis
-
Publication number: 20030064028Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.Type: ApplicationFiled: August 28, 2002Publication date: April 3, 2003Inventors: David H. Fine, Stephen J. MacDonald, David Rounbehler, David Wheeler, Jonathan L. Rolfe, George Jarvis
-
Publication number: 20030062043Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.Type: ApplicationFiled: August 28, 2002Publication date: April 3, 2003Inventors: David H. Fine, Stephen J. MacDonald, David Rounbehler, David Wheeler, Jonathan L. Rolfe, George Jarvis
-
Publication number: 20010037810Abstract: A nitric oxide delivery system for delivering nitric oxide to a patient to treat a medical condition includes a container, a nitric oxide generation chamber, and a pump. The container is designed to contain a nitrogen-containing compound. The nitric oxide generation chamber includes a heat source and is designed to generate nitric oxide from the nitrogen-containing compound. The pump is designed to transfer at least a part of the nitrogen-containing compound from the container to the nitric oxide generation chamber..Type: ApplicationFiled: January 26, 2001Publication date: November 8, 2001Inventors: David H. Fine, Freeman W. Fraim, George Jarvis